SoftBank and Hanwha-backed biomanufacturer Zymergen floated at the top of its range in an upsized offering following over $870m in venture funding.

The Medtronic and Johnson & Johnson-backed epilepsy treatment system provider floated at the top of its range and saw its shares rise 47% on their first day.

The LinkedIn-backed data streaming platform developer, valued at $4.5bn a year ago, is preparing an initial public offering.

Affirm is acquiring the e-commerce returns management provider for $300m in cash and shares, two years after taking part in its series B round.

Razer Green Fund will be overseen by the gaming accessory producer's corporate venture capital subsidiary, zVentures.

QCP Capital has reinvested in the decentralised exchange protocol developer, which also counts Binance and Bitlink Capital as existing backers.

The decentralised finance services provider has announced the first participant in its newly launched incubator for blockchain startups.

University of Auckland’s Rain Therapeutics has priced shares at $17 each to raise $125m in its initial public offering.

R3 Development Fund has backed a range of early-stage blockchain and confidential computing technology developers that leverage the corporate’s Corda and Conclave tools.

Ajinomoto set up its CVC unit in December and the deal with Pegasus’s 16 offices will provide access to startups.